There’s a leaner strategic approach to anti-drug antibody (ADA) assessments to support nonclinical #toxicology studies. In this session expert Katherine Malone describes a fit-for-purpose method and explores a change in paradigm from a lengthy multi-tier assessment to a leaner screening-only assay. Watch now: https://okt.to/1ueAdl
Charles River Laboratories
Biotechnology Research
Wilmington, Massachusetts 189,351 followers
Together, We Create Healthier Lives
About us
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
- Website
-
http://criver.com
External link for Charles River Laboratories
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Wilmington, Massachusetts
- Type
- Public Company
- Founded
- 1947
- Specialties
- Research Models & Services, Preclinical Services, Discovery Research Services, Biologics Testing Solutions, Microbial Identificiation, Endotoxin Testing, LAL, Early Discovery, Safety Testing, and Agrochemical
Locations
-
Primary
251 Ballardvale Street
Wilmington, Massachusetts 01887, US
Employees at Charles River Laboratories
-
Tracy Vachon
-
Michelle Berthiaume
Senior Director Global Change Management at Charles River Laboratories
-
Nick Hong
Associate Director, Global Categories Procurement at Charles River Laboratories
-
Tim DiMacchia, MBA
A results-oriented executive with a proven track record in driving technological excellence and innovation.
Updates
-
Positive collaboration ensures success for your drug development program. Learn how our #Kansas facility reduces your development timelines and costs through collaboration and long-term partnerships with governance. https://okt.to/qUTbio
-
Using a phase-appropriate approach, our recombinant off-the-shelf AAV and LVV viral vectors and plasmids make for more simplified gene therapy development. Empower breakthroughs in your discovery phase and start with the end in mind with a complete concept to cure portfolio through Charles River. Empower Your Research: https://okt.to/KTzQ5e
-
Vital Science tells the stories behind the science from the perspective of patients, scientists, employees, and advocated that have felt its impact. Listen and subscribe today. https://okt.to/1aoYrW
-
-
Streamline your research model ordering process with our enhanced real-time online platform! Discover the benefits of our innovative ordering system: - Intuitive, interactive catalog - Customizable orders - Downloadable quotes with institutional pricing - Dynamic inventory and shipping information - Immediate order confirmation Explore the difference today! https://okt.to/CIP9Gx #EfficientOrdering #ResearchInnovation
-
In the rapidly advancing field of drug development, transitioning from nonclinical to clinical phases is pivotal. Ensuring robust #bioanalytical methods is essential for data accuracy and reliability. In this webinar, you’ll discover essential insights on analytical method validation, addressing logical challenges, and leveraging advanced techniques to enhance your clinical studies. Explore key considerations such as: - Analytical Method Validation: Essential strategies for performance and stability - Logistical Challenges: Maintaining sample integrity across trial sites - Advanced Techniques: Sophisticated methods in both the LCMS and ligand binding assay for precise data - Collaborative Approaches: Enhancing studies with experienced providers so you can sharpen your understanding and drive success through your clinical phases Unlock your insights today. https://okt.to/QuWOjd #Bioanalysis #DrugDevelopment #AnalyticalServices
-
-
Taking a new approach to drive rare disease drug development, patient advocacy group FOXG1 Research Foundation is collaborating with our CDMO team to advance its gene therapy program. “The success of FRF’s model is not only focused on operating as a highly efficient team, but also partnering with organizations that are equally passionate about bringing treatments to children with the highest unmet need and severe burden of disease. Selecting the right partner is critical and Charles River has demonstrated a deep understanding of our model and commitment to working on our therapies,” Nasha Fitter, FOXG1 parent, co-founder, and CEO. Read the press release in full: https://okt.to/KetnUO #genetherapy #concepttocure #raredisease #foxg1syndrome
-
Introducing Weilyn H., one of our exceptional interns at Charles River Laboratories! Weilyn is instrumental in the care of diverse animal species at our Wilmington facility, taking on responsibilities such as feeding, watering, cleaning enclosures, and enhancing the animals' environments. His internship has provided him with indispensable practical experience in biology, enriching his understanding of animal physiology and behavior. We feel very lucky to have Weilyn as part of our team! #LIFEatCRL #InternSpotlight
-
-
#Agrochemical companies, are you aware it’s your responsibility to comply with EFSA’s Transparency Regulation (TR)? Preparing your data is a tedious and time-consuming process and failure to comply can have serious legal repercussions for your organization. Learn more about TR and how our regulatory consultants can support you with our expertise in confidentiality submissions. https://okt.to/yD1JP0
-
-
“Captain T Cell is devoted to developing a new generation of toolbox-engineered T cell-based immunotherapies for solid tumor patients. We have the utmost confidence in the expertise of Charles River as we work to bring our lead candidate to the clinic.” Felix Lorenz, CEO, Captain T Cell Once infused into a patient’s body, these tumor-specific T cells seek to find and destroy tumor cells and may provide an alternative for patients with tumors that no longer respond to other therapies. Read the story in full: https://okt.to/icLxaS #genemodifiedcelltherapy #genetherapy #tcelltherapy #immunotherapy #viralvectors
-